Hindustan Bio Sciences Limited (BOM:532041)

India · Delayed Price · Currency is INR

9.34

+0.26 (2.86%)

At close: May 11, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Trading of Drugs and Medicines	8.13M	10.53M	9.22M	4.31M	10.32M
Trading of Drugs and Medicines Growth	-22.75%	14.15%	114.19%	-58.27%	-46.90%
Total	8.13M	10.53M	9.22M	4.31M	10.32M
Total Growth	-22.75%	14.15%	114.19%	-58.27%	-46.90%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Exports	7.86M	10.39M	8.97M	4.31M	5.16M
Exports Growth	-24.31%	15.79%	108.38%	-16.56%	-1.05%
Unallocated	268.00K	137.00K	250.33K	-	103.39K
Unallocated Growth	95.62%	-45.27%	-	-	1105.60%
India	-	-	-	-	5.06M
India Growth	-	-	-	-	-64.42%
Total	8.13M	10.53M	9.22M	4.31M	10.32M
Total Growth	-22.75%	14.14%	114.19%	-58.27%	-46.90%

Source: S&P Global Market Intelligence.